CROs offering Translational Research with Synthetic Biology
Translational Research combined with Synthetic Biology is a common shortlist filter for sponsors evaluating CRO partners. This explore page lists organizations that publicly map to both dimensions, so you can move from taxonomy browsing to a tighter candidate set without rebuilding filters from scratch.
Profiles here are fit-first: open each listing for scope, geography, regulatory posture, and provenance-backed facts. The directory does not rank these rows as a single "best" answer — use them to assemble a right-sized outreach list for your program stage and quality bar.
When you need adjacent criteria (indications, claim status, or cross-category search), continue to the main search experience and layer filters on top of this service × modality starting point.
Auto-generated by BioBM Editorial AI.
Matching companies
- Clutch Biotechnologies, Inc.
Clutch Biotechnologies provides modular plasmid design and DNA cloning services to research teams with high iteration needs, offering a dedicated DNA build team, reusable DNA parts libraries, and centralized project management to reduce cost and turnaround time.
- Noble Life Sciences
Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.
- Pharmaron
Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Related: Translational Research service page · Synthetic Biology modality page
Markdown mirror: /explore/svc_translational_research/mod_synthetic_biology.md